We’re thrilled to announce that our own Mark Shapiro, Vice President of Clinical Development, and Renee Hart, Vice President of Strategic Accounts, will be sharing their expertise at the Phacilitate Oncology Leaders’ Forum on Tuesday, March 24th, in Boston. Their presentation, “Reducing Operational and Logistical Challenges in Immunoncology Trials,” will include information on anti-cancer immunotherapy site and country selection, study enrollment, manufacturing, and logistical considerations.

The Phacilitate Oncology Leaders’ Forum is the event of choice for senior translational and clinical oncology R&D executives driving the development, registration and launch of novel cancer therapeutics of all classes, plus companion diagnostics.

According to the website, this year will involve taking a hard look at recent trends, successes and failures, delivering invaluable insights into what the next strategic steps should be to drive the successful oncology therapeutics of tomorrow into and through the clinic. To learn more or register, visit their website.